SAB Biotherapeutics Inc. Gains 41.56%

Tue, Apr 18, 2023 at 07:10 PM
SAB Biotherapeutics Inc. Gains 41.56%

SAB Biotherapeutics Inc. (SABS:NASDAQ) soared at $1.09, representing a gain of 41.6%. On Tue, Apr 18, 2023, SABS:NASDAQ touched a New 2-Week High of $1.09. The stock got featured on our News Catalysts scanner on Tue, Apr 18, 2023 at 09:12 AM in the 'BIOTECH' category. From Tue, Apr 04, 2023, the stock recorded 33.33% Up Days and 50.00% Green Days

The stock spiked on Tue, Apr 18, 2023 at $1.45 with a volume of 37M+.

About SAB Biotherapeutics Inc. (SABS:NASDAQ)

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company advancing a class of immunotherapies based on its human polyclonal antibodies.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.